Woman sitting alone on a couch by a window, looking down pensively with hand near her face

Who Should Consider GeneSight Testing for Depression?

People who have tried more than one antidepressant with little relief, who struggle with hard-to-tolerate side effects, who have a family history of medication problems, or who live with treatment-resistant depression should consider GeneSight testing. This pharmacogenomic test offers genetic insights that can guide a more personalized approach to medication selection, moving beyond trial and error.

 

At Rooted in Care, we use GeneSight as part of genetic testing for mental health to refine depression treatment for patients in Orlando, FL, and virtually across Florida.

 

What Is GeneSight Testing for Depression?

GeneSight is a pharmacogenomic test that analyzes how your genes may affect your outcomes with certain psychiatric medications. It is not a diagnostic tool and does not tell you that you “have depression in your genes.”

  • Looks at genes that affect how quickly you break a drug down, how strongly you respond, and how likely you are to feel certain side effects

  • Simple, non-invasive cheek swab at our Orlando office or from home for virtual patients

  • Sample is sent to a lab; results return to your provider

  • Used alongside a psychiatric assessment, symptom history, past medication response, and ongoing follow-up

  • Deepens your individual health profile so findings can shape a plan that matches your biology, symptoms, and goals

 

Two people can take the same antidepressant and have very different results. One may feel better in a few weeks; another may feel worse, foggy, or no different at all. Part of that difference can be genetic, and GeneSight helps explain it so medication choices are not based on trial and error alone.

 

Who Should Consider GeneSight Testing?

At Rooted in Care, we find this test most beneficial for individuals in the situations below. If you identify with one or more, discussing genetic testing with one of our providers could be a productive next step.

 

Multiple Medications Tried Without Success

If you have tried two or more antidepressants – SSRIs, SNRIs, or others – and still feel stuck, genetics may be part of the reason. It can feel discouraging to wait the typical 4–8 weeks and find that sadness, fatigue, and hopelessness remain unchanged. A long list of past medicines is not a personal failure; it is a signal that the usual sequence may not match your biology.

  • Some people metabolize certain drugs so quickly that a usual dose never builds up

  • Others process them so slowly that even a modest dose feels too strong

  • GeneSight can offer clues as to why previous attempts failed and point toward alternatives better aligned with your genetic profile

  • Bring a list of what you have tried, how long you took each one, and what you noticed

 

Unbearable Side Effects from Current Medications

Sometimes a medication helps depression, but the side effects outweigh the benefits. Common reactions include persistent nausea, agitation, insomnia, sexual dysfunction, emotional blunting, “brain zaps,” fatigue, or significant weight gain. If every medicine you try leaves you feeling worse in a new way, GeneSight testing can show whether your body is processing those drugs unexpectedly.

  • The report can flag medications with a higher genetic potential for side effects

  • Your provider can steer toward options your body is more likely to process without a strong negative reaction

  • Side effects should never be something you are asked to “just live with” if another option exists

 

Family History of Medication Issues

Have you heard parents, siblings, or a child talk about how a certain antidepressant “didn’t work” or “made them feel awful”? Families can share the way they respond to medicine, and a family story is a clue, not a diagnosis. A GeneSight test provides concrete data about your specific genes, moving beyond anecdotal history to a personalized roadmap.

  • Useful for first-time treatment as well as for people who have already tried several medicines

  • Tell your provider what you know about relatives’ medication experiences, even if the information is partial

 

Treatment-Resistant Depression

Treatment-resistant depression (TRD) is clinically defined as depression that does not respond to at least two different antidepressant trials from different classes. Living with TRD is exhausting and can make you feel as if nothing will ever work. GeneSight will not unlock a hidden cure, but it can show whether past medicines were a poor genetic match and guide a more directed next choice.

  • May point toward a different class of medication or a different dose strategy

  • Can help guide augmentation strategies with a higher probability of success

  • Your provider will still look at sleep, medical issues, trauma, and other mental health conditions that can keep depression in place

  • Rooted in Care treats depression as part of a wider set of mood and related concerns

 

Preference to Avoid Trial-and-Error Prescribing

Even if you are new to depression treatment, you may want to be as proactive as possible from the start. Some people are sensitive to medications in general, have medical conditions that make extra side effects risky, or simply want to reduce the number of switches. Choosing GeneSight arms you and your provider with more information and narrows the field for a first or second medication decision.

  • Aligns with a patient-focused philosophy that prioritizes a personalized approach

  • A good fit for patients who want data before they commit to a new prescription

 

Who May Not Need GeneSight Testing

Not everyone with depression needs this test. If you are doing well on your current medicine, or if you are starting an antidepressant for the first time with no specific concerns and no family history of medication problems, your provider may recommend a standard first-line option. GeneSight is also not a stand-in for therapy, sleep repair, or treatment of other conditions that travel with depression, such as anxiety, ADHD, or trauma-related symptoms.

  • Testing is offered when it is likely to change a decision, not as a default for every new patient

  • If those other issues are the main drivers of how you feel, genetic data about antidepressants will only be one piece of a larger plan

  • Your nurse practitioner will help you decide

 

Next Steps: Is GeneSight Right for You?

If your depression care has felt like a loop of new prescriptions and the same disappointment, it is reasonable to ask whether genetic testing belongs in the next visit. Book a psychiatric assessment at Rooted in Care with one of our experienced psychiatric nurse practitioners, either in Orlando, FL or virtually anywhere in Florida. During that visit, your provider can review your history and tell you whether GeneSight is likely to change the plan.

  • If testing is appropriate, results can be built into a medication strategy more specific to you

  • If testing is not the right move yet, you still leave with a clearer picture of what to try and how progress will be measured

  • The point is not to order every test; the point is to stop guessing when better information is available

 

Conclusion

GeneSight testing may be a valuable option for people whose depression treatment has involved repeated medication trials, difficult side effects, treatment resistance, or concerns about how they may respond to antidepressants based on family history. While it cannot predict exactly which medication will work or replace a comprehensive psychiatric evaluation, pharmacogenomic insights can give providers another tool for making more informed, personalized treatment decisions.

 

At Rooted in Care, our providers can review your symptoms, treatment history, and goals to determine whether GeneSight testing could help guide the next step in your depression care.

Woman with teal wavy hair, tattoos, and gold jewelry in circular teal frame

About the Author

E. Blaine Guelde‑Patel

Blaine Guelde-Patel is an integrative nurse practitioner with over 20 years of experience focused on medication management, mental health, and whole-person wellness.

Ready to be truly listened to?

Woman with teal wavy hair, tattoos, and gold jewelry in circular teal frame
E. Blaine Guelde‑Patel

August 26, 2026